Filtered By:
Management: Budgets

This page shows you your search results in order of date. This is page number 3.

Order by Relevance | Date

Total 83 results found since Jan 2013.

TCT 2017: Boston Scientific touts lowered hemorrhagic stroke rate, cost for patients in Watchman studies
Boston Scientific (NYSE:BSX) today released combined 5-year outcomes data from both the Prevail and Protect-AF study of its Watchman left atrial appendage closure device, touting it as a safe and effective an alternative to long-term warfarin therapy for patients with non-valvular atrial fibrillation. Five-year data from the Prevail study was published online today in the Journal of the American College of Cardiology. In both trials, the Marlborough, Mass.-based company compared the Watchman device to warfarin treatment for stroke prevention in patients with non-valvular AF with follow-ups out to five years. A combined an...
Source: Mass Device - November 2, 2017 Category: Medical Devices Authors: Fink Densford Tags: Cardiac Implants Cardiovascular Clinical Trials Boston Scientific Source Type: news

Budget Impact Analysis (BIA) Of Mechanical Thrombectomy In Acute Phase Of Ischemic Stroke (AIS)
To estimate financial consequences of reimbursement of mechanical thrombectomy (MT) using a stent retriever in patients with AIS in Poland.
Source: Value in Health - October 1, 2017 Category: International Medicine & Public Health Authors: M Pochopien, T Fundament, G Niesyczynski, A Lembas, R Plisko Source Type: research

Budget Impact of Alteplase In Treatment of Acute Ischemic Stroke In Turkey
Cerebrovascular diseases are the sixth cause of total DALYs in Turkey and the Turkish Social Security Institution (SSI) faces a challenge on reimbursement decisions for treatment. Alteplase is a recombinant human tissue plasminogen activator indicated for treatment of acute ischemic stroke (AIS). Clinical trials have proved efficacy in reducing 90-day disability measured by the Modified Rankin Score (mRS) if administered within 4,5 hours of onset of symptoms. The agent is used as an addition to Standard of Care (SoC).
Source: Value in Health - October 1, 2017 Category: International Medicine & Public Health Authors: M Tatar, A Şentürk, E Tetik, L Yıldız, J Cheynel Source Type: research

Budget Impact of Post-Stroke Dysphagia: Database Analyses of Hospital Discharges In France And Switzerland
Oropharyngeal dysphagia is prevalent in hospitalized post-stroke patients and is associated with increased mortality and comorbidities. The aim of our analysis was to evaluate the impact of dysphagia on Length of Hospital Stay (LOS) and costs. The hospital perspective was used to assess costs.
Source: Value in Health - October 1, 2017 Category: International Medicine & Public Health Authors: N Muehlemann, L de L éotoing, B Jouaneton, J Fernandes, M Arnold, G Kägi Source Type: research

MassDevice.com +5 | The top 5 medtech stories for September 15, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. FDA cuts could threaten medtech innovation: Here’s why The Trump administration’s proposed federal budget could hurt the speed and quality of FDA review times, says a top expert at Musculoskeletal Clinical Regulatory Advise...
Source: Mass Device - September 15, 2017 Category: Medical Devices Authors: MassDevice Tags: News Well Plus 5 Source Type: news

Mind the Treatment Gap
getty images/ istock photoBy Vani S. Kulkarni and Raghav GaihaPHILADELPHIA AND NEW DELHI, Apr 14 2017 (IPS)Implementation of the Mental Healthcare Act will require a restructuring of health-care services The Mental Healthcare Bill, 2016, which was passed in the Lok Sabha on March 27, 2017, has been hailed as a momentous reform. According to the Bill, every person will have the right to access mental health care operated or funded by the government; good quality and affordable health care; equality of treatment and protection from inhuman practices; access to legal services; and right to complain against coercion and cruelt...
Source: IPS Inter Press Service - Health - April 14, 2017 Category: Global & Universal Authors: Vani Kulkarni and Raghav Gaiha Tags: Asia-Pacific Development & Aid Gender Gender Violence Headlines Health Human Rights Women's Health Source Type: news

Neurological Diseases Cost The U.S. $800 Billion Each Year
Over 100 million Americans ― close to a third of the total population ― suffer from neurological diseases such as Alzheimer’s, multiple sclerosis, migraines, epilepsy and spinal cord injury.  These conditions put an enormous financial strain on the health care system, totaling nearly $800 billion in annual costs, according to a new report published in the journal Annals of Neurology. To put that into perspective, the figure exceeds the U.S. military budget by over $100 billion.  That number reflects the total cost of the nine most common neurological diseases, but the total costs related to th...
Source: Healthy Living - The Huffington Post - March 30, 2017 Category: Consumer Health News Source Type: news

4 Key Insights When Raising Money for Your Medtech Startup: Interview with Bruce Shook, CEO of Intact Vascular
Welcome to the Medsider interview series, a regular feature at MassDevice. All interviews are conducted by Scott Nelson, Founder of Medsider and Group Director for WCG. We hope you enjoy them! Bruce Shook joined Intact Vascular in 2014 as President and CEO. A highly-experienced, medical device executive with more than 30 years of industry experience, Bruce was previously Co-founder, Director, President, and CEO of Neuronetics, which is a privately held medical device company that markets a non-invasive brain stimulation technology for the treatment of depression. Previously, Shook was Co-founder, Director, President, an...
Source: Mass Device - February 27, 2017 Category: Medical Equipment Authors: Danielle Kirsh Tags: Blog medsider Source Type: news

Prevention of central nervous system sequelae in sickle cell disease without evidence from randomized controlled trials: the case for a team-based learning collaborative.
Authors: DeBaun MR, King AA Abstract Since 1998, the National Institutes of Health has funded 5 randomized controlled trials (RCTs) for primary and secondary prevention of strokes in children with sickle cell anemia (SCA). In a systematic fashion, these trials have significantly advanced the care of children with SCA. In the absence of an RCT, clinicians are often compelled to make decisions at the bedside, based on experience, observational studies, and principles of hematology. We will provide an initial example that describes how a team-based, learning collaborative developed a multisite standard care protocol w...
Source: Hematology ASH Education Program - December 4, 2016 Category: Hematology Tags: Hematology Am Soc Hematol Educ Program Source Type: research

Call for Tender: Innovative Post-Stroke Tool
The European pre-commercial procurement MAGIC project has launched its call for tender to find suppliers who can develop and test solutions to improve stroke recovery, home-based rehabilitation and to empower stroke patients following hospital discharge. The budget for this call is about €3,6 million.
Source: eHealth News EU - November 2, 2016 Category: Information Technology Tags: Featured Industry Business and Industry Source Type: news

Tau Imaging Among Breakthroughs Advancing the Fight against Alzheimer ' s
Worldwide,  nearly44 million  people now have Alzheimer ' s disease (AD) or related dementia, making these conditions the  top cause of disabilities in later life. The biopharma industry has invested billions of dollars into research to treat and prevent AD1, yet this work has faced many obstacles, including difficulty identifying biomarkers, tracking the disease ’s progress in the brain, and recruiting patients to trials while they are still asymptomatic. But in recent years, we’ve begun to see breakthroughs that is driving our research in new directions. Many of these accomplishments were highlighted at the Alzh...
Source: EyeForPharma - September 21, 2016 Category: Pharmaceuticals Authors: Olga Uspenskaya-Cadoz Source Type: news

Prevention and treatment of cardiovascular disease in Ethiopia: a cost-effectiveness analysis
The coverage of prevention and treatment strategies for ischemic heart disease and stroke is very low in Ethiopia. In view of Ethiopia ’s meager healthcare budget, it is important to identify the most cost-effe...
Source: Cost Effectiveness and Resource Allocation - August 12, 2016 Category: Health Management Authors: Mieraf Taddesse Tolla, Ole Frithjof Norheim, Solomon Tessema Memirie, Senbeta Guteta Abdisa, Awel Ababulgu, Degu Jerene, Melanie Bertram, Kirsten Strand, St éphane Verguet and Kjell Arne Johansson Source Type: research

ACR Preliminary Summary of Radiology Provisions in the 2017 MPFS Proposed Rule
The Centers for Medicare and Medicaid Services (CMS) released the Medicare Physician Fee Schedule (MPFS) proposed rule on Thursday, July 7. Upon initial review, the American College of Radiology (ACR) is pleased with several provisions within the rule. CMS has recognized the value provided by radiologists in providing mammography services through an increase in the physician work relative value units (RVUs) for diagnostic mammography and maintaining the current value for screening mammography. Additionally, ACR physicians and staff held numerous conference calls and meetings with CMS on the topic of appropriate use criteri...
Source: American College of Radiology - July 8, 2016 Category: Radiology Source Type: news

The Economic Benefits Of Healthier Eating: Why Corporations Can Be Natural Allies To Promote Better Diets
Nutrition is at the heart of many of the most important issues in our lives. From nourished children to vibrant aging, from social justice to sustainability, how we eat plays a major role in our health, our culture, and our happiness. Yet, we rarely consider the tremendous economic impact of our food choices. Suboptimal nutrition is the leading cause of poor health in the United States and globally, principally related to chronic diseases such as heart disease, stroke, obesity, diabetes, and several cancers. In many nations, the costs of healthcare dwarf other programs in the national budget. In the United States, nearly ...
Source: Healthy Living - The Huffington Post - July 1, 2016 Category: Consumer Health News Source Type: news

The Uptake of Non-Vitamin K Oral Anticoagulants in Ireland: Balancing Cost-Effectiveness Analysis and Budget Impact
For many years vitamin K antagonists (usually warfarin) were the only oral anticoagulants available to reduce stroke risk in Atrial fibrillation (AF). The non-vitamin K oral anticoagulants (NOACs) were first licensed in Ireland for stroke prevention in non-valvular AF with the approval of dabigatran etexilate in 2011. Rivaroxaban followed later that year, apixaban in 2013 and edoxaban in 2015. The National Centre for Pharmacoeconomics (NCPE) reviewed all the NOACs for cost-effectiveness prior to reimbursement approval in Ireland.
Source: Value in Health - April 30, 2016 Category: Global & Universal Authors: M Barry, S Clarke, N Geraghty Source Type: research